Article
Synthesis and Comparative Evaluation of 177 Lu-labeled PEG and non-PEG variant peptides as HER2-targeting probes
2022-05-11
Abstract excerpt
Highest global cancer incidence of female breast cancer is a matter of great concern. HER2-positive breast cancers have high mortality rate hence detection at an early stage is vital for successful treatment, improved cancer care and survival rate. Radiolabeled peptides have emerged as new alternatives to radiolabeled antibodies to overcome the limitations of slow clearance and uptake in non-target tissues. Herein...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced biosensing and bioanalysis techniques
- Advanced Biosensing Techniques and Applications
- CAR-T cell therapy research
- Glycosylation and Glycoproteins Research
- HER2/EGFR in Cancer Research
- Immunotherapy and Immune Responses
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Identifiers and source
- Literature Corpus work
- 191d97ac-b9da-549e-9436-17b22d7238f1
- DOI
- 10.21203/rs.3.rs-1583288/v1
